Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Dental Research
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Shugars, D.C.
Right arrow Articles by Fiscus, S.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shugars, D.C.
Right arrow Articles by Fiscus, S.A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Hyper-excretion of Human Immunodeficiency Virus Type 1 RNA in Saliva

D.C. Shugars

School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7450, USA, School of Medicine, CB 7450, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7450, USA, diane_shugars{at}dentistry.unc.edu

L.L. Patton

School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7450, USA

S.A. Freel

School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7450, USA

L.R. Gray

School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7450, USA

R.T. Vollmer

Durham Veterans Administration and Duke Medical Centers, Durham, NC, USA

J.J. Eron, JR

School of Medicine, CB 7450, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7450, USA

S.A. Fiscus

School of Medicine, CB 7450, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7450, USA

Anatomical compartments (e.g., the reproductive tract) are reservoirs of human immunodeficiency virus type-1 (HIV-1) and potential sites of residual infection in patients receiving anti-retroviral therapy (ART). Viral hyper-excretion relative to blood is a hallmark of reservoirs. To determine whether hyper-excretion can occur in the oral cavity, we compared viral loads in blood plasma and saliva of 67 adults. Salivary viral hyper-excretion was defined as a four-fold or higher viral load in saliva than in plasma. HIV-1 RNA was detected in 79% of plasma samples, in 44% of unfiltered saliva samples, in 16% of filtered saliva samples, and in 59% of saliva-derived cell pellets. Compared with non-hyper-excretors (n = 62), hyper-excretors (n = 5) had elevated levels of viral RNA in unfiltered saliva and saliva-derived cells, HIV-associated periodontal disease, gingival inflammation, and no combination ART. Morphological characterization of cell pellets identified lymphocytes as a likely HIV-1 source. These collective findings are consistent with an oral HIV-1 reservoir in selected individuals.

Key Words: Human immunodeficiency virus • saliva • blood • viral load • anti-retroviral therapy

Journal of Dental Research, Vol. 80, No. 2, 414-420 (2001)
DOI: 10.1177/00220345010800020301


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
CVIHome page
S. H. Kazmi, J. R. Naglik, S. P. Sweet, R. W. Evans, S. O'Shea, J. E. Banatvala, and S. J. Challacombe
Comparison of Human Immunodeficiency Virus Type 1-Specific Inhibitory Activities in Saliva and Other Human Mucosal Fluids
Clin. Vaccine Immunol., October 1, 2006; 13(10): 1111 - 1118.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
H. Xie, N. I. Belogortseva, J. Wu, W.-H. Lai, and C.-h. Chen
Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Binding Domain of Porphyromonas gingivalis Gingipain.
Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3070 - 3074.
[Abstract] [Full Text] [PDF]


Home page
ADRHome page
M. Umadevi, O. Adeyemi, M. Patel, P.A. Reichart, and P.G. Robinson
(B2) Periodontal Diseases and Other Bacterial Infections
Advances in Dental Research, April 1, 2006; 19(1): 139 - 145.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. A. Acheampong, Z. Parveen, L. W. Muthoga, V. Wasmuth-Peroud, M. Kalayeh, A. Bashir, R. Diecidue, M. Mukhtar, and R. J. Pomerantz
Molecular Interactions of Human Immunodeficiency Virus Type 1 with Primary Human Oral Keratinocytes
J. Virol., July 1, 2005; 79(13): 8440 - 8453.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. L. Wood, P. Chaiyarit, R. B. Day, Y. Wang, C. T. Schnizlein-Bick, R. L. Gregory, and H. L. Twigg III
Measurements of HIV Viral Loads From Different Levels of the Respiratory Tract
Chest, August 1, 2003; 124(2): 536 - 542.
[Abstract] [Full Text] [PDF]